Patents by Inventor Derek Mendy

Derek Mendy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CK1 alpha AND DUAL CK1 alpha / GSPT1 DEGRADING COMPOUNDS
    Publication number: 20240158370
    Abstract: Provided herein are compounds that act as molecular glues, inducing degradation of CK1? or CK1?/GSPT1, and pharmaceutically acceptable derivatives thereof. Also provided are pharmaceutical compositions containing the compounds and methods of using the compounds for treating a subject with a proliferative disease.
    Type: Application
    Filed: September 6, 2023
    Publication date: May 16, 2024
    Inventors: Patrick W. Papa, Veronique Plantevin-Krenitsky, Paul J. Krenitsky, Frank Mercurio, Derek Mendy, Michael P. Haughey, Weilin Xie, Jan Elsner, John Sapienza
  • Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
    Patent number: 10047151
    Abstract: Uses of the protein cereblon as a predictor of clinical sensitivity to cancer, inflammatory diseases, and patient response to drug treatment.
    Type: Grant
    Filed: May 9, 2016
    Date of Patent: August 14, 2018
    Assignee: CELGENE CORPORATION
    Inventors: Antonia Lopez-Girona, Peter H. Schafer, Anita Gandhi, Derek Mendy, Thomas O. Daniel
  • METHODS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES USING CEREBLON AS A PREDICTOR
    Publication number: 20160319005
    Abstract: Uses of the protein cereblon as a predictor of clinical sensitivity to cancer, inflammatory diseases, and patient response to drug treatment.
    Type: Application
    Filed: May 9, 2016
    Publication date: November 3, 2016
    Inventors: Antonia Lopez-Girona, Peter H. Schafer, Anita Gandhi, Derek Mendy, Thomas O. Daniel
  • Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
    Patent number: 9365640
    Abstract: Uses of the protein cereblon as a predictor of clinical sensitivity to cancer, inflammatory diseases, and patient response to drug treatment.
    Type: Grant
    Filed: April 27, 2012
    Date of Patent: June 14, 2016
    Assignee: CELGENE CORPORATION
    Inventors: Antonia Lopez-Girona, Peter H. Schafer, Anita Gandhi, Derek Mendy, Thomas O. Daniel
  • METHODS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES USING CEREBLON AS A PREDICTOR
    Publication number: 20120322073
    Abstract: Uses of the protein cereblon as a predictor of clinical sensitivity to cancer, inflammatory diseases, and patient response to drug treatment.
    Type: Application
    Filed: April 27, 2012
    Publication date: December 20, 2012
    Inventors: Antonia Lopez-Girona, Peter H. Schafer, Anita Gandhi, Derek Mendy, Thomas O. Daniel